Dr Dan Furkert discusses his search for antiviral drugs that can reduce the impact of the Covid-19 pandemic. He is a Senior Research Fellow at the School of Chemical Science in The University of Auckland.
The work of Dr Daniel Furkert and his team forms a small part of an encouragingly rapid and highly cooperative worldwide effort to develop and evaluate many possible antiviral drugs, to identify those few that can be advanced through clinical trials into therapeutic use. The drug class they are investigating has a strong record in successful use against other pathogens including hepatitis, so there is a proven pathway for these agents to be successfully developed using a rational design process.
Enjoy this video of our recent free webinar series and read more about this work funded by Auckland Medical Research Foundation's emergency Covid-19 Research Fund.